Skip to Main content Skip to Navigation
Journal articles

Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-01626345
Contributor : Carole Brunaud <>
Submitted on : Monday, October 30, 2017 - 4:22:03 PM
Last modification on : Monday, August 31, 2020 - 9:52:06 AM

Links full text

Identifiers

Citation

B. Chauffert, L. Feuvret, F. Bonnetain, L. Taillandier, Didier Frappaz, et al.. Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†. Annals of Oncology, Elsevier, 2014, 25 (7), pp.1442 - 1447. ⟨10.1093/annonc/mdu148⟩. ⟨hal-01626345⟩

Share

Metrics

Record views

141